Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: intellectual property
Astrazeneca v Apotex – Patent That Label!
I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading
Judge Goes Medieval On Spoilating Defendants
This summary of Victor Stanley v. Creative Pipe et al., provided by Ron Schutz of Robins, Kaplan, Miller & Ciresi is a cautionary tale for patent prosecutors served with subpoenas (or about to be). If the appropriate steps are not … Continue reading
In re Glatt Air Techniques – Glatt Sailing for Applicants
In re Glatt Air Techniques, Inc. (January 5, 2011) (link below), the Fed. Cir. in dicta reminded the PTO that evidence of commercial success – unlike a showing of unexpected results –need not be commensurate in scope with the claims … Continue reading
Posted in Obviousness
Tagged Federal Circuit, Glatt Air, intellectual property, ip, IP law tools, Patent Law, patents, Warren Woessner
Leave a comment
EMA Draft Guidelines For Biosimilar Antibodies Released
From Dr. Stefan Danner On November 18, 2010, the European Medicines Agency (EMA) released draft versions of two guidelines relating to the regulatory approval of monoclonal antibodies: the “Guideline on biological medicinal products containing monoclonal antibodies”1 and the “Guideline on … Continue reading
Posted in Non-U.S. Practice
Tagged biotechnology law, Dr. Stefan Danner, EMA, intellectual property, Warren Woessner
Leave a comment